Abstract:

Depression and anxiety disorders (DAD) have consistently been established as some of the major mental health outcomes in the HIV/AIDS population. In light of previous research attempts to examine its causes and proffer solutions, however, rates of DAD have remained consistently high, especially in HIV populations. This study therefore examined the prevalence of depression, anxiety and coping strategies among HIV naïve patients in Abuja. The research design was a descriptive cross-sectional survey that utilized multistage sampling technique to recruit 1022 HIV naïve patients. Patient Health Questionnaire (PHQ), generalized anxiety scale (GAD-7) and developed instruments for coping were used to assess depression, anxiety and coping strategies respectively. The research instrument was administered to well-consented and eligible participants. Three objectives, which were later transformed into hypotheses, examined the prevalence of depression, anxiety and coping strategies. Data was analyzed using descriptive analysis, Chi-square and logistic regression. Results indicated that the prevalence of depression was 65.1%, 18.8%, 10.8% and 5.3% for minimal, mild, moderate and severe depression respectively. Similarly, the prevalence of anxiety was 69.5%, 20.6%, 7.6% and 2.3% for minimal, mild, moderate and severe anxiety respectively. Further results revealed that sex is significantly associated with depression and anxiety X² = 21.597, df= 4, p<.000; X² = 12.480, df= 4, p<.05. There was also a statistically significant difference in coping between patients with mild depression and severe depression (OR. 2.673 to 29.949). Also, there was a statistically significant difference in coping between patients with mild and severe anxiety (OR, 2.673 to 29.949). Governmental and Non-governmental organizations should take cognizance of this prevalence and evolve measure to reduce the rate of these problems among HIV naïve patients in Abuja and beyond.

References:

[1].   World Health Organization. 2023. HIV Statistics, Globally and by WHO Region. Accessed from https://cdc.who.int.

[2].   Onovo, A. A., Adeyemi, A., Onime, D., Kalnoky, M., and Kagniniwa, M., 2023. Estimation of HIV Prevalence and Burden in Nigeria: A Bayesian Predictive Modelling Study. eClinicalMedicine., 6, Doi: https://doi.org/10.1016/j.eclinm.2023.1020983

[3].   Rooney, A. S., Moore, R. C., Paolillo, E. W, et al., 2019, Depression and Aging with HIV: Associations with Health-Related Quality of Life and Positive Psychological Factors. Journal of Affect Disordor, 15, P. 251, 1–7. Doi: https://doi.org/10.1016/j.jad.2019.03.025

[4].   Cai, S., Liu, L., Wu, X., Pan, Y., Yu, T., and Ou, H., 2020, Depression. Anxiety, Psychological Symptoms and Health-Related Quality of Life in People Living with HIV. Patient Prefer Adherence, 14, P. 1533–40. Doi: https://doi.org/10.2147/PPA.S263007.

[5].   Agyemang, S. O., Ninonni, J. and Bennin, L., 2022, Prevalence and Associations of Depression, Anxiety, and Stress among People Living with HIV: A Hospital‐Based Analytical Cross‐Sectional Study. Health Science Reports, 5:e754. Doi: https://doi.org/10.1002/hsr2.754

[6].   Bernard, C., Dabis, F., and de Rekeneire, N., 2017, Prevalence and Factors Associated with Depression in People Living with HIV in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. PLoS ONE, 12 (8), e0181960. Doi: https://doi.org/10.1371/journal.pone.0181960.

[7].   Adeoti, A. O., Dada, M. U., and Fadare, J., O. 2018, Prevalence of Depression and Anxiety Disorders in People Living with HIV/AIDS In a Tertiary Hospital in South Western Nigeria. Medical Reports & Case Studies, 3(1). Doi: https://doi.org/10.4172/2572-5130.1000150

[8].   Egbe, C. O., Dakum, P. S., Ekong, E., Kohrt, B. A., Minto, J. G. and Ticao, C. J. 2017, Depression, Suicidality, and Alcohol Use Disorder Among People Living with HIV/AIDS in Nigeria. BMC Public Health, 17(1), 542. https://doi.org/10.1186/s12889-017-4467-5

[9].   Yun, L. W., Maravi, M., Kobayashi, J. S., Barton, P. L., and Davidson, A. J. 2005, Antidepressant Treatment Improves Adherence to Antiretroviral Therapy among Depressed HIV-Infected Patients. JAIDS, 38 (4), P. 432–438. https://doi.org/10.1097/01.qai.0000147524.19122.fd.

[10].  Adeoti, A. O., Dada, M., Elebiyo, T., Fadare, J., and Ojo, O. 2022. Survey of Antiretroviral Therapy Adherence and Predictors of Poor Adherence Among HIV Patients in a Tertiary Institution in Nigeria. Pan African Medical Journal, 33. Doi: https://doi.org/10.11604/pamj.2019.33.277.18711

[11].  Pence, B. W. 2018, Association of Increased Chronicity of Depression with HIV Appointment Attendance, Treatment Failure, and Mortality among HIV-Infected Adults in the United States. JAMA Psychiat, 75(4), P. 379–385. https://doi.org/1001/jamapsychiatry.2017.4726

[12].  Simbayi, L. C., Kalichman, S., Strebel, A., Cloete, A., Henda, N., and Mqeketo, A. 2007. Internalized Stigma, Discrimination, and Depression among Men and Women Living with HIV/AIDS in Cape Town, South Africa. Soc Sci Med., 64 (9), P. 1823–1831. Doi: https://doi.org/10.1016/j.scocscmed.2007.01.006

[13].  Topcu, G, 2023. Experiences of Receiving A Diagnosis of Multiple Sclerosis: A Meta-Synthesis of Qualitative Studies. Disability Rehabilitation, 45(5), P. 772–783. Doi: https://doi.org/10.1080/09638288.2022.2046187

[14].  Saliva, R. T. S., Silva, R. A. R., Rodrigues, I. D. C. V., Souza Neto, V. L., Silva, B. C. O., and Souza, F. M. L. C., 2018. Coping Strategies of People Living with AIDS in Face of the Disease. Revista Latino-Americana de Enfermagem, 26, e2985. Doi: https://doi.org/10.1590/1518-8345.2985

[15].  Al-Bahrani, M, Aldhafri, S, Alkharusi, H, Kazem, A. and Alzubiadi, A. 2013. Age and Gender Differences in Coping Style Across Various Problems: Omani Adolescents' perspective. Journal of Adolescence, 36, 2, P. 303-309. https://doi.org/10.1016/j.adolescence.2012.11.007.

[16].  Gupta, A., Gupta, K., and Kumar, A., 2021. Age and Gender Differences in Coping Strategies Used by Individuals During COVID-19 in India. The International Journal of Indian Psychology, 9, 2. DOI: https://doi.org/10.25215.0902.076

[17].  Zhao, L., Han, G., Zhao, Y, Jin, Y., Ge, T., Yang, W., Cui, R., Xu, S., and Li, B., 2020. Gender Differences in Depression: Evidence From Genetics. Front. Genet., 11:562316. Doi: https://doi.org/10.3389/fgene.2020.562316

[18].  Wang, P., Li, B., Fan, J., Zhang, K., Yang, W., Ren, B., et al. 2019. Additive Antidepressant-Like Effects of Fasting with B-Estradiol In Mice. J. Cell. Mol. Med., 23, P. 5508–5517. Doi: https://doi.org/10.1111/jcmm.14434

[19].  Farhane-Medina, N. Z., Luque, B., Tabernero, C., and Castillo-Mayén, R., 2022. Factors Associated with Gender and Sex Differences in Anxiety Prevalence and Comorbidity: A Systematic Review. Sci Prog, 105(4):368504221135469. Doi: https://doi.org/10.1177/00368504221135469

[20].  Sikström, S., Kelmendi, B., and Persson, N., 2023. Assessment of Depression and Anxiety in Young and Old with a Question-Based Computational Language Approach. npj Mental Health Research, 2:11.; https://doi.org/10.1038/s44184-023-00032-z.

[21].  Lenze, E. J. et al. Comorbid Anxiety Disorders in Depressed Elderly Patients. Am. J. Psychiatry, 2000, 157, P. 722–728. https://doi.org/10.1080/09638288.2022.2046187

[22].  Spitzer, R. L., Kroenke, K., Williams, J. B., Löwe, B., 2006. A Brief Measure for Assessing Generalized Anxiety Disorder: the GAD-7. Archives of Internal Medicine, 166(10), P. 1092-1097. Doi: https://doi.org/10.1001/archinte.166.10.1092